Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Healthcare Medical Devices
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet’s Clinical Team

Business Wire June 10, 2016

Insulet to Present Omnipod® Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association’s 76th Scientific Sessions

Business Wire June 8, 2016

Insulet Launches New Omnipod® Podder™ Community Platform

Business Wire May 23, 2016

Insulet Reaffirms Second Quarter and Full Year 2016 Guidance

PR Newswire May 3, 2016

Insulet Reports First Quarter 2016 Financial Results

PR Newswire April 28, 2016

Insulet Corporation to Announce First Quarter 2016 Financial Results on April 28, 2016

PR Newswire March 30, 2016

Insulet Names Aiman Abdel-Malek, Ph.D. Senior Vice President of Advanced Technology and Engineering

PR Newswire March 16, 2016

Insulet Announces Organizational Enhancements

PR Newswire March 2, 2016

Insulet Corporation to Present at Upcoming Investor Conference

PR Newswire February 29, 2016

Insulet Reports Fourth Quarter and Full Year 2015 Financial Results

PR Newswire February 25, 2016

Insulet Announces Development Partner for the OmniPod Artificial Pancreas

PR Newswire February 25, 2016

Insulet Appoints David A. Lemoine to Board of Directors

PR Newswire February 9, 2016

Insulet to Divest Neighborhood Diabetes Supplies Business

PR Newswire February 2, 2016

Insulet Corporation to Announce Fourth Quarter and Full Year 2015 Financial Results on February 25, 2016

PR Newswire January 25, 2016

Insulet Raises Funds for Continued Diabetes Research

PR Newswire January 19, 2016

Insulet Enters into Development Agreement with Eli Lilly for OmniPod Delivery of U200 Concentrated Insulin

PR Newswire January 11, 2016

Insulet Corporation to Present at Upcoming Investor Conference

PR Newswire January 11, 2016

Insulet Partners with Glooko as its Preferred Data Management Partner for OmniPod Patients and Healthcare Providers

PR Newswire January 5, 2016

Insulet Corporation to Present at Upcoming Investor Conferences

PR Newswire November 13, 2015

Insulet Corporation Recognizes National Diabetes Awareness Month at NASDAQ Stock Market Opening Bell Ceremony

PR Newswire November 13, 2015